158 related articles for article (PubMed ID: 29532879)
1. Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.
Yang J; Bo L; Han T; Ding D; Nie M; Yin K
Mol Med Rep; 2018 May; 17(5):6345-6356. PubMed ID: 29532879
[TBL] [Abstract][Full Text] [Related]
2. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of prognosis prediction models based on pathway‑level, gene‑level and clinical information for glioblastoma.
Liang R; Wang M; Zheng G; Zhu H; Zhi Y; Sun Z
Int J Mol Med; 2018 Oct; 42(4):1837-1846. PubMed ID: 30015853
[TBL] [Abstract][Full Text] [Related]
4. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
6. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
7. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
9. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
[No Abstract] [Full Text] [Related]
10. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
12. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer.
Li S; Yu C; Cheng Y; Du F; Wen G
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495829
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer.
Wu Z; Wang L; Wen Z; Yao J
Sci Rep; 2021 Feb; 11(1):3292. PubMed ID: 33558567
[TBL] [Abstract][Full Text] [Related]
15. Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer.
Zheng S; Zhang Z; Ding N; Sun J; Lin Y; Chen J; Zhong J; Shao L; Lin Z; Xue M
BMC Gastroenterol; 2021 Apr; 21(1):146. PubMed ID: 33794777
[TBL] [Abstract][Full Text] [Related]
16. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
Liu Y; Zhu D; Xing H; Hou Y; Sun Y
Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
Sun M; Qiu J; Zhai H; Wang Y; Ma P; Li M; Chen B
Med Sci Monit; 2020 Aug; 26():e924604. PubMed ID: 32740646
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
19. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Dai DQ
Pathol Res Pract; 2019 May; 215(5):893-899. PubMed ID: 30718100
[TBL] [Abstract][Full Text] [Related]
20. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
Fei HJ; Chen SC; Zhang JY; Li SY; Zhang LL; Chen YY; Chang CX; Xu CM
Int J Oncol; 2018 Mar; 52(3):955-966. PubMed ID: 29328368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
